Grady Mike, Cameron Hilary, Holt Elizabeth
LifeScan Scotland Ltd, Beechwood Park North, Inverness, IV2 3ED, UK.
LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, USA.
Diabetes Ther. 2023 Jun;14(6):1023-1035. doi: 10.1007/s13300-023-01415-3. Epub 2023 May 3.
The OneTouch Verio Reflect (OTVR) Blood Glucose Meter features a color range indicator and provides on-meter guidance, insights, and encouragement. Diabetes management is enhanced by the OneTouch Reveal (OTR) Mobile App. We sought to provide real-world evidence (RWE) that combining devices improves glycemia.
Anonymized glucose and app analytics from more than 55,000 people with diabetes (PWDs) were extracted from a server. Data from their first 14 days using OTVR Meter and OTR App was compared with 14 days prior to 90- and 180-day timepoints using paired within-subject differences.
In people with type 1 (PwT1D) or type 2 diabetes (PwT2D), readings in-range (RIR 70-180 mg/dL) improved by 7.8 percentage points (57.9-65.7%) and 12.0 percentage points (72.8-84.8%), respectively, over 180 days and hyperglycemia (> 180 mg/dL) was reduced by - 8.4 percentage points (37.9-29.5%) and - 12.2 percentage points (26.2-14.1%). RIR improved by > 10 percentage points in 38% of PwT1D and 39% of PwT2D. PwT1D spending > 2 to 4 sessions or > 10 to 20 min per week on the app improved RIR by 7.0 and 8.2 percentage points, respectively. PwT2D spending > 2 to 4 sessions or > 10 to 20 min per week on the app improved RIR by 12.6 and 12.1 percentage points, respectively. In PwT1D or T2D, mean blood glucose reduced by - 14.3 and - 19.8 mg/dL, respectively, from baseline to 180 days, with no clinically meaningful changes in percentage of hypoglycemic readings (< 70 mg/dL). PwT1D 65 years and older performed the most app sessions (10 per week) and improved RIR by 7.9 percentage points. PwT2D 65 years and older spent more time on the app (45 min per week) than PwT2D of any other age and improved RIR by 7.6 percentage points. All glycemic changes were statistically significant (p < 0.0005).
Real-world data from more than 55,000 PWDs demonstrates sustained improvements in readings in-range in PWDs using the OneTouch Verio Reflect Blood Glucose Meter and OneTouch Reveal App.
OneTouch Verio Reflect(OTVR)血糖仪具有颜色范围指示器,并提供血糖仪上的指导、见解和鼓励。OneTouch Reveal(OTR)移动应用程序可增强糖尿病管理。我们试图提供真实世界证据(RWE),证明联合使用这些设备可改善血糖水平。
从服务器中提取了来自超过55000名糖尿病患者(PWD)的匿名血糖和应用程序分析数据。使用配对的受试者内差异,将他们使用OTVR血糖仪和OTR应用程序的前14天的数据与90天和180天时间点之前的14天数据进行比较。
在1型糖尿病患者(PwT1D)或2型糖尿病患者(PwT2D)中,180天内血糖读数在正常范围内(RIR 70 - 180mg/dL)分别提高了7.8个百分点(57.9 - 65.7%)和12.0个百分点(72.8 - 84.8%),高血糖(>180mg/dL)分别降低了 - 8.4个百分点(37.9 - 29.5%)和 - 12.2个百分点(26.2 - 14.1%)。38%的PwT1D和39%的PwT2D的RIR提高超过10个百分点。PwT1D每周在应用程序上花费超过2至4次或超过10至20分钟,RIR分别提高了7.0和8.2个百分点。PwT2D每周在应用程序上花费超过2至4次或超过10至20分钟,RIR分别提高了12.6和12.1个百分点。在PwT1D或T2D中,从基线到180天,平均血糖分别降低了 - 14.3和 - 19.8mg/dL,低血糖读数(<70mg/dL)的百分比没有临床意义上的变化。65岁及以上的PwT1D进行的应用程序会话最多(每周10次),RIR提高了7.9个百分点。65岁及以上的PwT2D在应用程序上花费的时间比其他任何年龄的PwT2D都多(每周45分钟),RIR提高了7.6个百分点。所有血糖变化均具有统计学意义(p < 0.0005)。
来自超过55000名PWD的真实世界数据表明,使用OneTouch Verio Reflect血糖仪和OneTouch Reveal应用程序的PWD的血糖读数在正常范围内持续改善。